Clinical Trials Logo

Clinical Trial Summary

Nefopam is a benzoxazocine derivative which is non-opioid and non NSAIDs. The previous studies showed that nefopam can inhibit reuptake of serotonin, norepinephrine and dopamine. It has no respiratory depression so may be useful in potential airway compromized surgery like anterior cervical discectomy and fusion (ACDF). This study aims to study the analgesic properties of nefopam after ACDF.


Clinical Trial Description

The investigators enroll 50 patient who admitted for ACDF. Standard general anesthesia will be performed in all of the patients. Then, an hour before finishing operation, the patients will be divided into two groups. The first group will receive Nefopam 20 mg infuse for 60 min. The another group or group NSS will receive the same amount of 0.9% sodium chloride. The recorded data include patient demographic data, intraoperative blood loss, hemodynamics and pre and postoperative pain scores and Thai version of the Neuropathic Pain Symptom Inventory (NPSI-T score). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03955705
Study type Interventional
Source Mahidol University
Contact
Status Enrolling by invitation
Phase N/A
Start date May 15, 2019
Completion date May 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT04222777 - Cervical Spine Motion in the Elderly N/A
Withdrawn NCT05408923 - Randomized Controlled Trial Comparing Irrisept Versus Normal Saline for Wound Irrigation After Posterior Spine Surgery Phase 4
Withdrawn NCT03312192 - Stand-Alone Cage Verus Anterior Plating for Anterior Cervical Discectomy and Fusion. N/A
Recruiting NCT06202443 - Improving Surgical Outcomes With Early PT After ACDF N/A
Completed NCT06428981 - Surgical Intervention on the Body-mind-spirit of Patients With Cervical Spine Surgery N/A